Evofem Biosciences (EVFM) Selling, General & Administrative (2014 - 2026)
Evofem Biosciences (EVFM) posted Selling, General & Administrative of $1.83 million for Q2 2026, down 0.8% from $1.84 million a year earlier and down 22.9% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Selling, General & Administrative (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Evofem Biosciences was $7.39 million, down 30.9% year-over-year; for FY2025, it was $7.39 million, down 36.1% from FY2024.
- Annual Selling, General & Administrative has declined for three consecutive years, with a five-year compound annual growth rate of -24.5% (FY2020 to FY2025).
- In prior years, Evofem Biosciences' Selling, General & Administrative was $11.57 million in FY2024 (-22.6%), $14.95 million in FY2023 (-45.8%), $27.56 million in FY2022 (+11.6%) and $24.71 million in FY2021 (-17.9%).
- Quarterly Selling, General & Administrative has run from a low of $1.1 million in Q4 2025 to a high of $9.13 million in Q2 2022 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in two of the last eight quarters, with an average decline of 16.7%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2022, with growth of 42.2%; the weakest was Q4 2025, with a decline of 67.9%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $2.37 million (Q1 2026), $1.1 million (Q4 2025) and $2.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | 1.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 3.42 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 2.82 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 3.16 Mn |
| Sep 30, 2022 | 6.26 Mn |
| Jun 30, 2022 | 9.13 Mn |
| Mar 31, 2022 | 9.02 Mn |
| Dec 31, 2021 | 5.65 Mn |
| Sep 30, 2021 | 4.96 Mn |
API Access
Evofem Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();